Search Results 761-770 of 16056 for pharmacogenetics

1. FT819 in Subjects With B-cell Malignancies - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

2. Philip W. Tipton, M.D. - Doctors and Medical Staff - Mayo Clinic

   Tipton is an assistant professor and senior associate consultant in the Department of Neurology at Mayo Clinic in Jacksonville, FL, where he has served since ...

3. Todd and Karen Wanek Family Program for HLHS - Clinical Trials

   Todd and Karen Wanek Family Program for HLHS at Mayo Clinic: HLHS clinical trials on genetic screening, bone marrow, umbilical cord blood banking, more.

4. Clinical trials - Oncology (Medical)

   The purpose of this trial is to identify cancer survivors who are at increased risk of developing late-occurring complications after undergoing treatment ...

5. Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery - Mayo Clinic

   Irinotecan may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as cetuximab and bevacizumab, ...

6. GMCI Plus Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

7. Mayo Clinic Confirms Genetic Predictor for Fuchs' Corneal Dystrophy

   ROCHESTER, Minn. — May 4, 2012. Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a ...

8. Trial of Multi-epitope HER2 Peptide Vaccine in Patients with HER2-expressing DCIS - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. A Study to Evaluate CHIP and Hematological Toxicity After PRRT in Neuroendocrine Tumor Patients - Mayo Clinic

   About this study. The purpose of this study is to combine robust clinical data (e.g., prior chemotherapy or radiation exposure, cumulative Peptide Receptor ...

10. Alumni - Genitourinary Pathology Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    Program outcomes and additional training opportunities after the Genitourinary Pathology Fellowship Fellowship at Mayo Clinic in Rochester, Minnesota.